Renata Zaucha

3.6k total citations · 1 hit paper
54 papers, 1.1k citations indexed

About

Renata Zaucha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Renata Zaucha has authored 54 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Renata Zaucha's work include Cancer Immunotherapy and Biomarkers (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Diagnosis and Treatment (5 papers). Renata Zaucha is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Cancer Diagnosis and Treatment (5 papers). Renata Zaucha collaborates with scholars based in Poland, United States and Italy. Renata Zaucha's co-authors include Jan Maciej Zaucha, William Bensinger, Yavuz Anacak, Leszek Kraj, Mary E.D. Flowers, Rainer Storb, Thomas R. Chauncey, Jan Storek, Theodore A. Gooley and Beverly Torok‐Storb and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.

In The Last Decade

Renata Zaucha

49 papers receiving 1.0k citations

Hit Papers

A phase 3 randomized, double-blind, placebo-controlled st... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.
    2022 159 citations Aiwu Ruth He, Shukui Qin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renata Zaucha Poland 16 455 297 232 193 166 54 1.1k
Salvatore Berretta Italy 17 423 0.9× 174 0.6× 102 0.4× 151 0.8× 157 0.9× 45 834
Emiko Sakaida Japan 17 186 0.4× 160 0.5× 143 0.6× 373 1.9× 149 0.9× 103 866
Doug Stewart Canada 15 273 0.6× 100 0.3× 257 1.1× 97 0.5× 457 2.8× 25 1.0k
G. Janka‐Schaub Germany 18 345 0.8× 228 0.8× 312 1.3× 491 2.5× 113 0.7× 30 1.5k
Narendranath Epperla United States 17 452 1.0× 116 0.4× 94 0.4× 115 0.6× 267 1.6× 147 1.0k
Dae Sik Kim South Korea 15 172 0.4× 234 0.8× 141 0.6× 132 0.7× 81 0.5× 73 782
Kathleen Jentsch‐Ullrich Germany 15 148 0.3× 141 0.5× 89 0.4× 313 1.6× 243 1.5× 46 882
Kelvin Lee United States 15 211 0.5× 176 0.6× 137 0.6× 210 1.1× 85 0.5× 39 730
Parvesh Kumar United States 20 423 0.9× 364 1.2× 540 2.3× 84 0.4× 113 0.7× 43 1.2k
Shakil H. Merchant United States 16 251 0.6× 193 0.6× 251 1.1× 71 0.4× 65 0.4× 22 805

Countries citing papers authored by Renata Zaucha

Since Specialization
Citations

This map shows the geographic impact of Renata Zaucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Zaucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Zaucha more than expected).

Fields of papers citing papers by Renata Zaucha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Zaucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Zaucha. The network helps show where Renata Zaucha may publish in the future.

Co-authorship network of co-authors of Renata Zaucha

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Zaucha. A scholar is included among the top collaborators of Renata Zaucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Zaucha. Renata Zaucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daneshmand, Siamak, Renata Zaucha, James W.F. Catto, et al.. (2025). Erdafitinib in Patients with High- and Intermediate-risk Non–muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study. European Urology. 89(2). 165–173.
2.
Daneshmand, Siamak, Renata Zaucha, Nikhil Vasdev, et al.. (2024). MARKER LESION STUDY OF ORAL ERDAFITINIB IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE–INVASIVE BLADDER CANCER WITH FGFR3/2 ALTERATIONS IN THOR-2: UPDATED COHORT 3 RESULTS. Urologic Oncology Seminars and Original Investigations. 42. S58–S58. 1 indexed citations
3.
Nowicka, Zuzanna, et al.. (2024). Changes in Systemic Immune Response and Its Dosimetric Correlates in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 120(2). e392–e393. 1 indexed citations
4.
5.
Zaucha, Renata, et al.. (2024). Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review. Frontiers in Oncology. 13. 1215426–1215426. 1 indexed citations
6.
Piotrowska, Anna, et al.. (2023). Vitamin D Modulates the Response of Patient-Derived Metastatic Melanoma Cells to Anticancer Drugs. International Journal of Molecular Sciences. 24(9). 8037–8037. 10 indexed citations
7.
Musiał, Claudia, Narcyz Knap, Renata Zaucha, et al.. (2022). Induction of 2-hydroxycatecholestrogens O-methylation: A missing puzzle piece in diagnostics and treatment of lung cancer. Redox Biology. 55. 102395–102395. 10 indexed citations
8.
9.
Radziwon, Piotr, Maciej Krzakowski, Ewa Kalinka‐Warzocha, et al.. (2020). Niedokrwistość u chorych na nowotwory — zalecenia grupy ekspertów. Aktualizacja 2020 r.. Oncology in Clinical Practice. 16(5). 261–269. 2 indexed citations
10.
Radziwon, Piotr, Maciej Krzakowski, Ewa Kalinka‐Warzocha, et al.. (2017). Anaemia in cancer patients — Expert Group recommendations. Oncology in Clinical Practice. 13(5). 202–210. 6 indexed citations
11.
Kraj, Leszek, et al.. (2017). Nutritional status assessment in colorectal cancer patients qualified to systemic treatment. Współczesna Onkologia. 2(2). 157–161. 25 indexed citations
12.
13.
Krzakowski, Maciej, Piotr Rutkowski, Jacek Jassem, et al.. (2015). Recommendations on the application of positron emission tomography in oncology. Oncology in Clinical Practice. 11(4). 155–172. 1 indexed citations
14.
Weber, Damien C., Yucai Wang, Robert C. Miller, et al.. (2014). Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro-Oncology. 17(4). 588–595. 71 indexed citations
15.
Małkowski, Bogdan, Edyta Subocz, Justyna Rybka, et al.. (2014). Comparison of positron emission tomography/computed tomography with classical contrast-enhanced computed tomography in the initial staging of Hodgkin lymphoma. Leukemia & lymphoma. 56(2). 377–382. 17 indexed citations
16.
Plummer, Ruth, Paul Lorigan, Ewan Brown, et al.. (2013). Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma. British Journal of Cancer. 109(6). 1451–1459. 23 indexed citations
17.
Ruka, W., Maciej Krzakowski, Waldemar Placek, et al.. (2009). Czerniaki skóry - zasady postępowania diagnostyczno-terapeutycznego. Nowotwory Journal of Oncology. 5(1). 114–114. 4 indexed citations
18.
Zaucha, Jan Maciej, Iwona Danielewicz, Bogdan Małkowski, Renata Zaucha, & Krzysztof Leśniewski-Kmak. (2009). The role of PET for interim response assessment in patients with Hodgkin’s lymphoma. Contemporary Oncology/Współczesna Onkologia. 13(4). 161–166. 2 indexed citations
19.
Szczylik, Cezary, et al.. (2003). New staging system for cancer. Review of changes published in the sixth edition of the AJCC Cancer Staging Manual. Contemporary Oncology/Współczesna Onkologia. 7(10). 795–807. 1 indexed citations
20.
Zaucha, Renata, H Karnicka-Młodkowska, Marzena Wełnicka-Jaśkiewicz, & Jacek Jassem. (2003). Mediastinal malignant germ cell tumours: presentation of 15 cases and literature review. Nowotwory Journal of Oncology. 53(3). 265–265. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvatore Berretta Breakdown of academic impact, for papers by Emiko Sakaida Breakdown of academic impact, for papers by Doug Stewart Breakdown of academic impact, for papers by G. Janka‐Schaub Breakdown of academic impact, for papers by Narendranath Epperla Breakdown of academic impact, for papers by Dae Sik Kim Breakdown of academic impact, for papers by Kathleen Jentsch‐Ullrich Breakdown of academic impact, for papers by Kelvin Lee Breakdown of academic impact, for papers by Parvesh Kumar Breakdown of academic impact, for papers by Shakil H. Merchant
Rankless by CCL
2026